Agilent Technologies Inc., of Palo Alto, Calif., named Darlene Solomon vice president and director of Agilent Laboratories.
Alnylam Holding Co., of Cambridge, Mass., appointed Kevin Starr to its board.
Argenta Discovery Ltd., of Harlow, England, appointed Richard Lingard vice president, business development.
Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Paul Sekhri president and chief business officer, Timothy Clackson chief scientific officer, John Iuliucci chief development officer and Tomi Sawyer senior vice president, drug discovery.
ArQule Inc., of Woburn, Mass., named Chiang Li chief scientific officer and vice president, head of ArQule Biomedical Institute.
Axonyx Inc., of New York, appointed Gosse Bruinsma president and Gerard Vlak vice chairman of the board.
Bayhill Therapeutics Inc., of Palo Alto, Calif., added James Woody to its board.
The Biotechnology Industry Organization in Washington added Barbara Glenn as director of animal biotechnology and Hannah Highfill as director for international market access. Michael Phillips was promoted to vice president, food and agriculture, science and regulatory policy.
CollaGenex Pharmaceuticals Inc., of Newtown, Pa., appointed Paul Lubetkin senior vice president and general counsel.
Connetics Corp., of Palo Alto, named Lincoln Krochmal executive vice president, research and product development.
QuatRx Pharmaceuticals Co., of Ann Arbor, Mich., elected August Watanabe to its board.
Structural Genomix Inc., of San Diego, appointed Stephen Wasserman director of X-ray technology.
Targacept Inc., of Winston-Salem, N.C., added Jeffrey Brennan as vice president, business and commercial development.